These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25186025)

  • 41. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.
    Del Rosso JQ; Thiboutot D; Gallo R; Webster G; Tanghetti E; Eichenfield LF; Stein-Gold L; Berson D; Zaenglein A
    Cutis; 2014 Jan; 93(1):18-28. PubMed ID: 24505581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea.
    Laquieze S; Czernielewski J; Baltas E
    J Dermatolog Treat; 2007; 18(3):158-62. PubMed ID: 17538804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical effectiveness of novel rosacea therapies.
    Feaster B; Cline A; Feldman SR; Taylor S
    Curr Opin Pharmacol; 2019 Jun; 46():14-18. PubMed ID: 30639950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea.
    Benkali K; Leoni M; Rony F; Bouer R; Fernando A; Graeber M; Wagner N
    Br J Dermatol; 2014 Jul; 171(1):162-9. PubMed ID: 24506775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of rosacea with topical ivermectin cream: a series of 34 cases.
    Mendieta Eckert M; Landa Gundin N
    Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rosacea: a common, yet commonly overlooked, condition.
    Blount BW; Pelletier AL
    Am Fam Physician; 2002 Aug; 66(3):435-40. PubMed ID: 12182520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2017 Jul; 10(7):28-32. PubMed ID: 29104721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The treatment of rosacea with topical ivermectin.
    Ali ST; Alinia H; Feldman SR
    Drugs Today (Barc); 2015 Apr; 51(4):243-50. PubMed ID: 26020066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rosacea: where are we now?
    Bikowski JB; Goldman MP
    J Drugs Dermatol; 2004; 3(3):251-61. PubMed ID: 15176158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [PATHOGENETIC FEATURES AND METHODS FOR TREATMENT OF VARIOUS FORMS OF ROSACEA].
    Tsiskarishvili T; Katsitadze A; Tsiskarishvili NV; Tsiskarishvili NI; Chitanava L
    Georgian Med News; 2019 Apr; (289):116-120. PubMed ID: 31215891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of skin barrier function in rosacea patients with a novel 1% metronidazole gel.
    Draelos ZD
    J Drugs Dermatol; 2005; 4(5):557-62. PubMed ID: 16167413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ivermectin: A Review in Rosacea.
    Deeks ED
    Am J Clin Dermatol; 2015 Oct; 16(5):447-52. PubMed ID: 26254001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin.
    Allen KJ; Davis CL; Billings SD; Mousdicas N
    Cutis; 2007 Aug; 80(2):149-51. PubMed ID: 17944176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.
    Tong LX; Moore AY
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):567-77. PubMed ID: 25091290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea.
    Jackson JM; Fowler J; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M;
    J Drugs Dermatol; 2014 Jun; 13(6):699-704. PubMed ID: 24918560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rosacea: a review of current topical, systemic and light-based therapies.
    Kennedy Carney C; Cantrell W; Elewski BE
    G Ital Dermatol Venereol; 2009 Dec; 144(6):673-88. PubMed ID: 19907406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):s101-7. PubMed ID: 25607798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea.
    Wirth PJ; Henderson Berg MH; Sadick N
    Skin Therapy Lett; 2017 Nov; 22(6):5-7. PubMed ID: 29091380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.
    Steinhoff M; Vocanson M; Voegel JJ; Hacini-Rachinel F; Schäfer G
    Adv Ther; 2016 Sep; 33(9):1481-501. PubMed ID: 27432381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rosacea.
    Maor D; Chong AH
    Aust Fam Physician; 2017; 46(5):277-281. PubMed ID: 28472572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.